Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
about
The Rotterdam Study: 2010 objectives and design updateA critical review of diabetes, glycemic control, and dental implant therapyThe alliance of mesenchymal stem cells, bone, and diabetesAdvanced Glycation End Products, Diabetes, and Bone StrengthEpidemiology of Fractures in Diabetes.Diabetes mellitus and the risk of non-vertebral fractures: the Tromsø study.Lower bone mass in prepubertal overweight children with prediabetes.Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis.Identification of candidate gene regions in the rat by co-localization of QTLs for bone density, size, structure and strength.Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.The association between the serum C-peptide level and bone mineral density.Osteoporosis in men with diabetes mellitus.Rheumatic manifestations of diabetes mellitus.Diabetes, diabetic complications, and fracture risk.The Rotterdam Study: 2012 objectives and design update.Diabetes Mellitus: Does it Affect Bone?Association between low C-peptide and low lumbar bone mineral density in postmenopausal women without diabetesDiabetes, TZDs, and Bone: A Review of the Clinical Evidence.Novel insights into the relationship between diabetes and osteoporosisA Comparative Study of the Metabolic and Skeletal Response of C57BL/6J and C57BL/6N Mice in a Diet-Induced Model of Type 2 DiabetesWomen, type 2 diabetes, and fracture risk.Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies.Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.A growing troubling triad: diabetes, aging, and falls.Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators.Factors contributing to skeletal health of postmenopausal Mexican-American women.Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.Validity of leptin receptor-deficiency (db/db) type 2 diabetes mellitus mice as a model of secondary osteoporosisRole of vitamin D in the pathogenesis of type 2 diabetes mellitus.Diabetes and osteoporosis.Diabetes mellitus, thyroid dysfunctions and osteoporosis: is there an association?Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender DifferencesType 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies.Diabetes and skeletal health.Osteoporosis and risk of fracture in patients with diabetes: an update.Bone, sweet bone--osteoporotic fractures in diabetes mellitus.Antidiabetic therapy effects on bone metabolism and fracture risk.The prevention of fragility fractures in diabetic patients.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.An update on the potential role of C-peptide in diabetes and osteoporosis.
P2860
Q24653733-BBD9FDE4-E92D-4C46-8D67-44691E547F78Q27006805-1F602642-7B71-467E-BBD1-B0512DD3D65AQ27012497-2469462D-3899-48F0-8FD8-3A1F57F506C6Q28076977-68830FF3-1E41-41ED-9FCE-F7BDC965AFDAQ30248863-762D36BE-BCBA-46FF-9915-E334D1CFA605Q33226999-44C3127D-8E75-44E6-9495-1034D305CCC2Q33635583-EC016411-3085-4514-A66A-F507B812C0E9Q33812674-4D644894-D160-475A-BA2A-77A8EE8C05A3Q33983232-07CBD86B-DDA8-4E3D-8FDC-CD9DAED6C5FEQ35042276-50AD1A26-2377-48C1-8C1A-DA0D5659BCFAQ35072996-4FEB0ED4-C198-4BC4-A61B-91881D202338Q35101854-7D5E3C85-CF6C-44CA-9BF2-220477E19EEFQ35126648-C85B1AA0-DCF9-4F37-B6B3-E55DD3842BB1Q35156465-E84F74B6-5D75-4B3D-AC46-788148BC09D2Q35201574-AA41848E-0288-4EF1-8992-C0BE258387E1Q35546778-FF8BDC2E-D3F0-4334-8027-E7A2A27F15C7Q35597894-029A728D-B85B-431C-AF34-090029D71087Q35606042-6A4500A6-FC9C-4947-AF71-FD56D86E94D0Q35674683-09BD5150-B70D-45B4-9960-F089C6D181A1Q35749390-A4DED3CF-7712-4BE9-96AD-F7F0909C2271Q35907238-E6619936-9C89-4419-A7A2-424C0CEE8390Q36028626-93048845-8FB2-4F10-887B-9D3A0C0F0ECDQ36281802-114D2EC5-0BE3-4537-A107-F7391246B56FQ36651355-E17D4D41-31AC-4CE2-BBFB-0C17AAA6712BQ36715753-1E75E186-E578-4ED6-82B2-75CDEF767443Q36793658-2E2DF474-406B-4CDE-92B8-706E713C8770Q36830195-37403640-D2F7-44BC-AFD8-360A7A95DD54Q36990610-F6678176-5192-4A64-BA10-666CC4F5AB12Q37082949-9A34E3D5-1F0C-4D32-9554-FA987741B0C7Q37293002-79A14A9A-3943-47B4-94C6-FB385C7F8D88Q37357382-B98AB5F0-E40C-41F7-949B-15AA32D2EE04Q37511845-199C1A2B-7CED-47E3-8CCF-B818E90BFCDEQ37716849-3933D351-AA64-4F9A-AD0D-43B42AEF9DBDQ37798059-277C32CA-FBEE-4B02-A6CF-5C2B88E66B18Q37899709-4E1BF1C3-6319-4E98-AFF4-26AB7DF03603Q37976305-7FFAC0B4-603E-4FCD-BB15-74DA39C92193Q38078009-3C684306-A747-4023-A175-2E6E9DDEBAC8Q38233593-14CE2331-508E-49A4-8E25-8A6972A828BEQ38641190-D68B7E03-1A94-4BE4-842E-13BBD743F3FDQ38735440-1673C087-E915-4AFC-BBC6-EB8D8A986114
P2860
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
description
im März 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 1995
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1995
@uk
name
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@en
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@nl
type
label
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@en
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@nl
prefLabel
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@en
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
@nl
P2093
P1476
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study
@en
P2093
D E Grobbee
J C Birkenhäger
P L van Daele
P304
P356
10.7326/0003-4819-122-6-199503150-00002
P407
P577
1995-03-01T00:00:00Z